Indresh K Srivastava

USPTO Granted Patents = 10 (Patent Applications = 10)

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 3.8

ph-index = 2

Forward Citations = 16(Granted Patents)

Location History:

Concord, CA (US) (2010 - 2012)
Benicia, CA (US) (2010 - 2013)
Emeryville, CA (US) (2012 - 2014)

Company Filing History:

8 out of 245

Novartis Vaccines & Diagnostics, Gmbh

1 out of 833,002

Other

patents

Years Active: 2010-2014

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8637044 - Method of generating an immune response in a subject using fusion proteins comprising CD4 minimal modules and HIV Tat scaffold polypeptides that are capable of binding to the HIV envelope and exposing cryptic neutralization epitopes (2014-01-28),

2. 8568734 - Method for generating immune responses utilizing nucleic acids encoding fusion proteins comprising CD4 minimal modules and invasin polypeptides that are capable of binding to the HIV envelope and exposing cryptic neutralization epitopes (2013-10-29),

3. 8470334 - Method of inducing an antiviral immune response against HIV-1 utilizing chimeric HIV Env proteins comprising CD4 mini-proteins or CD4 mimetics (2013-06-25),

4. 8226955 - Chimeric HIV Env proteins comprising CD4 mini-proteins or CD4 mimetics that are capable of inducing neutralizing antibody responses against cryptic Env epitopes (2012-07-24),

5. 8206720 - Fusion proteins comprising CD4 minimal modules and invasin polypeptides that are capable of binding to the HIV envelope and exposing cryptic neutraliziation epitopes (2012-06-26),

6. 8197819 - Env polypeptide complexes and methods of use (2012-06-12),

7. 8168418 - Expression of HIV polypeptides and production of virus-like particles (2012-05-01),

8. 8168194 - Fusion proteins comprising CD4 minimal modules and human immunodeficiency virus (HIV) Tat scaffold polypeptides that are capable of binding to the HIV envelope and exposing cryptic neutralization epitopes (2012-05-01),

9. 7811580 - Chimeric HIV Env proteins comprising CD4 mini-proteins or CD4 mimetics that are capable of inducing neutralizing antibody responses against cryptic Env epitopes (2010-10-12),

10. 7718401 - Expression of HIV polypeptides and production of virus-like particles (2010-05-18),

Title: Indresh K Srivastava: Innovator in Immunology

Introduction

Indresh K Srivastava is a prominent inventor based in Benicia, CA (US). He has made significant contributions to the field of immunology, particularly in the development of innovative methods for generating immune responses against HIV. With a total of 10 patents to his name, his work has the potential to impact the future of vaccine development and treatment strategies.

Latest Patents

Among his latest patents, Srivastava has developed a method of generating an immune response in a subject using fusion proteins comprising CD4 minimal modules and HIV Tat scaffold polypeptides. These proteins are capable of binding to the HIV envelope and exposing cryptic neutralization epitopes. Additionally, he has described hybrid molecules that combine CD4 minimal modules or mimetics with HIV Tat polypeptides, along with methods for diagnosis, treatment, and prevention using these polynucleotides and polypeptides. Another notable patent involves generating immune responses utilizing nucleic acids encoding fusion proteins that bind to HIV Env polypeptides in a non-CD4 backbone.

Career Highlights

Indresh K Srivastava has worked with notable organizations, including Novartis Vaccines & Diagnostics, where he contributed to groundbreaking research in vaccine development. His expertise in immunology and innovative approaches have positioned him as a key figure in the field.

Collaborations

Throughout his career, Srivastava has collaborated with esteemed colleagues, including Susan Barnett and Victoria A Sharma. These partnerships have fostered a collaborative environment that enhances the research and development of new immunological therapies.

Conclusion

Indresh K Srivastava's contributions to immunology and his innovative patents reflect his dedication to advancing medical science. His work continues to pave the way for new treatments and preventive measures against HIV, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.